YM-181741, a Novel Benz[a]anthraquinone
Antibiotic with Anti-Helicobacter pylori Activity A novel benz [a] anthraquinone, YM-181741, was isolated from the culture broth of actinomycete strain Q57219. The strain was identified as Streptomyces sp. by morphological and chemotaxonomic characterization. YM-181741 was purified from the culture supernatant by serial column chromatography. The structure of YM-181741 was determined by spectroscopic analysis including one-and two-dimensional NMR experiments. YM-181741 Many recent studies have shown that peptic ulcer diseases are mainly caused by Helicobacter pylori (H. pylori) infection1,2). H. pylori is a microaerophilic, Gramnegative, spiral-shaped and flagellated bacterium, which is found only on gastric mucosa. Eradication of this bacterium dramatically decreases the recurrence rate in peptic ulcer patients. Treatment regimens including a proton pump inhibitor and antimicrobial agents such as amoxicillin and clarithromycin are now recommended3). However, these therapies have associated problems including side effects (e.g. diarrhea), build-up of drug resistance, and poor compliance4,5). Therefore, the development of a new class of anti-H. pylori agents is needed.
In the course of our screening for anti-H. pylori agents, 
Taxonomic Studies
Morphological, cultural and physiological properties were examined according to the methods described by SHIRLING and GOTTLIEB7). Morphological observations were made using scanning electron microscopy (JEOL T220). A slant culture of strain Q57219 grown on Bennett's agar was used to inoculate a 500-ml Erlenmeyer flask containing 100ml of a seed medium consisting of glucose 1%, potato starch 2%, Polypepton (Nihon Pharmaceutical Co., Ltd.) 0.5%, yeast extract 0.5%, and CaCO3 0.4% (pH 7.0). The a rotary shaker at 220rpm. This culture (3ml) was transferred to each of six 500-ml Erlenmeyer flasks containing 100ml of the seed medium to produce a second seed culture that was then incubated similarly. The second seed culture (3ml) was inoculated into each of two hundred 500-ml Erlenmeyer flasks containing 100ml of a production medium consisting of dextrin 5%, corn steep liquor 3%, Polypepton (Nihon Pharmaceutical Co., Ltd.) 0.1%, and CaCO3 0.5% (pH 7.0). The fermentation was 220rpm.
Isolation
The fermentation broth (20 liters) was filtered and the filtrate was applied to a Diaion HP-20 column. The column was washed with MeOH/H2O (8:2) and MeOH, and then eluted with acetone. The acetone eluate was partitioned between hexane and MeOH/H2O (9:1). The aqueous MeOH layer was subjected to silica gel column chromatography using CHCl3/MeOH (20:1) as an eluent.
The active fraction was then applied to a silica gel column and developed with hexane/EtOAc (1:2). The combined active fraction was finally purified by ODS HPLC on Cosmosil 5C18-AR with MeOH/H2O (6:4) to yield 1.9mg of 1.
Structure Determination
The physico-chemical properties of 1 are listed in Table   3 . The molecular formula of 1 was determined to be C19H14O5 by high-resolution FAB-MS and NMR data that also indicated thirteen degrees of unsaturation. The IR spectrum suggested the presence of hydroxyl groups (3420cm-1) and conjugated carbonyl groups (1700, 1680 and 1640cm-1). The 1H NMR and DEPT spectra revealed the presence of two methylenes, an oxygenated methylene, a methine, five aromatic methines, three conjugated Table 4 .
Analysis of one-and two-dimensional NMR spectra including COSY, HMQC and HMBC led to the assignment of two partial structures, a and b, as shown in Fig. 2 . In partial structure a, a 1,2,3-trisubstituted benzene ring moiety was easily assigned by interpretation of the COSY and HMBC spectra. An aromatic proton H-11 was correlated with C-12 in the HMBC spectrum, indicating linkage between C-11 a and C-12. Judging by the chemical 12.29) was attached to C-8. In partial structure b, the C2-C3(C13)-C4 and C5-C6 portions were assigned by tracing of cross peaks in the COSY spectrum. A cyclohexenone ring moiety was disclosed by HMBC correlations (H-2/C-1, C-12b; H-3/C-1, C-4a; H-4/C-4a, Ccorrelations (H5/C-4, C-6a, C-12b; H-6/C-4a, C-12a)
indicated the presence of a benzene ring moiety fused with which showed an HMBC correlation with H-6, could be located at C-7. Oxygenation of C-13 was inferred from its
The phenolic hydroxyl proton 8-OH was hydrogenbonded and H-6 gave a weak HMBC cross peak with C-12, indicating a connection between partial structures a and b.
The presence of a quinone moiety was supported by the Considering the molecular formula, the oxygen on C-13 had to be provided by a hydroxyl group. Thus, the planar structure of YM-181741 (1) was determined as shown in Fig. 1 . Structurally, YM-181741 is a novel member of the benz[a]anthraquinone antibiotics and is closely related to ochromycinone (2)10,11), which lacks a 13-hydroxyl group. The antimicrobial activities of YM-181741(1) are shown in 
YM-181741 (1) R=CH2OH
Ochromycinone (2) R=CH3 
